BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4039040)

  • 1. The antitumor activity of oxoplatinum.
    Presnov MA; Konovalova AL; Kozlov AM; Brovtsyn VK; Romanova LF
    Neoplasma; 1985; 32(1):73-83. PubMed ID: 4039040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
    Presnov MA; Konovalova AL
    Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effectiveness and nephrotoxicity of oxoplatinum].
    Aref'eva AK; Rykov VA; Mitrokhina LN
    Vopr Onkol; 1990; 36(3):331-4. PubMed ID: 2109913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the action of cis-dichlorodiammineplatinum and oxoplatinum on hemopoiesis un mice].
    Kulik GI; Korol' VI; Bondarenko TI
    Eksp Onkol; 1986; 8(6):70-2, 74. PubMed ID: 3803289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of the antitumor drug oxoplatinum labeled with 191Pt].
    Lobanova EA
    Med Radiol (Mosk); 1985 May; 30(5):75-8. PubMed ID: 4039785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of platinum complexes in athymic mice with human tumors].
    Bukharov IK; Osokina LI; Revazova ES; Moroz LV
    Vopr Onkol; 1988; 34(9):1084-7. PubMed ID: 3188435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA; Konovalova AL; Romanova LF; Sof'ina ZP; Stetsenko AI
    Vopr Onkol; 1978; 24(4):53-60. PubMed ID: 654174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation analysis with reactor and 14 MeV neutrons in an experimental study of oxoplatinum].
    Brovtsyn VK; Mikhaĭlov GP; Porokhov SP; Danilin VF
    Med Radiol (Mosk); 1986 May; 31(5):49-54. PubMed ID: 3713471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor properties of cis-dichlorodiamminedihydroxyplatinum (IV)].
    Presnov MA; Konovalova AL; Kozlov AM; Brovtsyn VK; Romanova LF
    Izv Akad Nauk SSSR Biol; 1986; (3):417-28. PubMed ID: 3734243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetic research on oxoplatinum].
    Lobanova EA; Singin AS; Moldovanova LK; Mas'ko AS
    Vestn Akad Med Nauk SSSR; 1986; (5):56-61. PubMed ID: 3727786
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
    Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
    J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of oxoplatin and platidiam on human melanoma strains and functional activity of blood lymphocytes in athymic mice].
    Bukharova IK; Osokina LI; Revazova ES
    Eksp Onkol; 1988; 10(5):55-7. PubMed ID: 3208691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of the toxic effects of cis-dichlorodiammineplatinum].
    Kulik GI; Chekhun VF; Pel'kis FP; Korol' VI; Boĭm TM
    Eksp Onkol; 1985; 7(6):55-8. PubMed ID: 4085400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonspecific oxidase activity in the liver of rats undergoing chemotherapy with cis-dichlorodiammineplatinum].
    Kulik GI; Pel'kis FP; Chekhun VF; Sidorik OA; Boĭm TM
    Eksp Onkol; 1984; 6(6):60-3. PubMed ID: 6543174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The phagocytic activity of the macrophages from mouse peritoneal exudate under the action of platinum preparations].
    Brin EV; Uteshev BS
    Biull Eksp Biol Med; 1990 Nov; 110(11):513-5. PubMed ID: 2083335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure-activity relations of antineoplastic platinum II and platinum IV coordination compounds].
    Gutsche W; Baumgart J; Schröer HP
    Arch Geschwulstforsch; 1989; 59(4):233-8. PubMed ID: 2802931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the complex platinum (IV) compound oxoplatinum on the immune system].
    Brin EV; Rytenko AN; Uteshev BS
    Farmakol Toksikol; 1990; 53(5):52-4. PubMed ID: 2253752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antidotal and antineoplastic properties of copper sulfate].
    Syrkin AB; Chlenova EL
    Biull Eksp Biol Med; 1988 Apr; 105(4):477-9. PubMed ID: 3359035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of transplantable mouse tumors with cis-dichlorodiammineplatinum(II) alone and in combination with sarcolysin.
    Presnov MA; Konovalova AL; Romanova LF; Sofina ZP; Stetsenko AI
    Cancer Treat Rep; 1978 May; 62(5):705-12. PubMed ID: 657156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.